Corning Incorporated vs Relay Therapeutics Inc. Common Stock — how do they compare? Corning Incorporated trades at $156.69 (market cap $131.65B), while Relay Therapeutics Inc. Common Stock trades at $17.88 (market cap $3.82B). The key difference: Corning Incorporated is far larger — about 34.5× Relay Therapeutics Inc. Common Stock's market cap, and Corning Incorporated pays a 0.73% dividend while Relay Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Corning Incorporated for 36 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| GLW | RLAY | |
|---|---|---|
Market Cap | $131.65B | $3.82B |
Volume | 8,992,522 | 4,332,079 |
Sector | Technology | Health |
52-Week High | $255.79 | $20.75 |
52-Week Low | $78.03 | $6.03 |
Typical Hold Time | 36 Days | 0 Days |
Enterprise Value | $138.52B | $2.93B |
Dividend Yield | 0.73% | — |
Signals from Pluang's Aura AI — not financial advice
Corning (GLW) trades at $152.81, down 6.37% amid a bearish technical signal, though it recently secured a significant $3 billion fiber supply deal with AT&T. The company shows strong earnings momentum with three consecutive quarterly beats and improved 2025 financials, including revenue growth to $15.63B and net income of $1.60B. Valuation ratios remain elevated with a P/E of 70.43, while analyst consensus is bullish with a $171.25 price target.
The outlook is mixed: the AT&T deal and earnings strength support growth, but high valuation and a bearish technical picture pose risks. Investors should weigh the company's positioning in AI-driven infrastructure against potential volatility from patent litigation and competitive pressures.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Corning Inc is a leader in materials science, specializing in the production of glass, ceramics and optical fiber. The firm supplies its products for a wide range of applications, from flat-panel displays in televisions to gasoline particulate filters in automobiles to optical fiber for broadband access, with a leading share in many of its end markets.
Read more on GLW →Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →